Music |
Video |
Movies |
Chart |
Show |
The latest in bladder cancer with FGFR 2 and 3 mutations (ecancer) View | |
TCGA: FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma - Rachel Liao (National Human Genome Research Institute) View | |
Erdafitinib demonstrates efficacy in intermediate-risk NMIBC with FGFR alterations (ecancer) View | |
Update on First Biomarker-Directed Trial of Non-Muscle-Invasive Bladder Cancer (Breakthroughs for Physicians) View | |
Molecular Testing and Treatment Sequencing for Advanced UC: Navigating FGFR-Targeted Therapy (GU Oncology Now) View | |
Case 3: FGFR-Targeted Therapy Adverse Events in Bladder Cancer (Targeted Oncology) View | |
The Future of FGFR Inhibitor Treatment (Targeted Oncology) View | |
FGFR Inhibitor Clinical Trials (Targeted Oncology) View | |
New FDA-Approved Therapy for Targeting FGFR Alterations In Advanced Urothelial Cancer (The Cancer Guy) View | |
FGFR screening - the pathologist perspective (European Association of Urology) View |